Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5543850 | 1.00 | CPB2 (0.33) | CPB2EPOR | |
| SCHEMBL7601678 | 0.96 | CPB2 (0.33) | CPB2EPOR | |
| SCHEMBL6232568 | 0.93 | EPOR (0.40) | CPB2EPOR | |
| SCHEMBL7881945 | 0.90 | CPB2 (0.36) | CPB2EPOR | |
| SCHEMBL6232124 | 0.89 | EPOR (0.40) | CPB2EPOR | |
| SCHEMBL4537445 | 0.88 | CPB2 (0.37) | CPB2EPOR | |
| SCHEMBL896853 | 0.88 | CPB2 (0.37) | CPB2EPOR | |
| SCHEMBL4564930 | 0.82 | TDP1 (0.31) | — | |
| SCHEMBL14345486 | 0.82 | TDP1 (0.31) | — | |
| SCHEMBL5032518 | 0.82 | TDP1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9907637-B2 | Modular bioresorbable or biomedical, biologically active supramolecular materials | SUPRAPOLIX B.V. (NL) | 2018-03-06 | — | — | US | disclosed |
| US-20160228229-A1 | MODULAR BIORESORBABLE OR BIOMEDICAL, BIOLOGICALLY ACTIVE SUPRAMOLECULAR MATERIALS | SUPRAPOLIX B.V. (NL) | 2016-08-11 | — | — | US | disclosed |
| US-8883188-B2 | Modular bioresorbable or biomedical, biologically active supramolecular materials | SUPRAPOLIX B.V. (NL) | 2014-11-11 | — | — | US | disclosed |
| US-20140234211-A1 | SUPRAMOLECULAR AGGREGATES CONTAINING AMPHIPHILIC MONOMERS, CHELATING AGENTS AND PEPTIDES FOR USE FOR DRUG DELIVERY AND AS CONTRAST AGENTS | INVECTORS S.R.L. (IT) | 2014-08-21 | — | — | US | disclosed |
| EP-1877113-B1 | MODULAR BIORESORBABLE OR BIOMEDICAL, BIOLOGICALLY ACTIVE SUPRAMOLECULAR MATERIALS | SUPRAPOLIX BV (NL) | 2011-11-09 | — | — | EP | disclosed |
| US-20090130172-A1 | Modular Bioresorbable or Biomedical, Biologically Active Supramolecular Materials | SUPRAPOLIX B.V. (NL) | 2009-05-21 | — | — | US | disclosed |
| EP-1877113-A2 | MODULAR BIORESORBABLE OR BIOMEDICAL, BIOLOGICALLY ACTIVE SUPRAMOLECULAR MATERIALS | SupraPolix B.V. (NL) | 2008-01-16 | — | — | EP | disclosed |
| WO-2006118461-A2 | MODULAR BIORESORBABLE OR BIOMEDICAL, BIOLOGICALLY ACTIVE SUPRAMOLECULAR MATERIALS | SUPRAPOLIX B. V. (NL) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234211-A1 | SUPRAMOLECULAR AGGREGATES CONTAINING AMPHIPHILIC MONOMERS, CHELATING AGENTS AND PEPTIDES FOR USE FOR DRUG DELIVERY AND AS CONTRAST AGENTS | GRPR, BRS3, BID | CPB2 1329/4885EPOR 2576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.